The Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU) has published its Annual Report on Access to Orphan Drugs in Spain 2025.

According to its findings, Spain funded a total of 20 orphan drugs (ODs) for rare diseases in 2025, which is three more than the previous year.

Access the full press release here